Skip to content
Clinical Trials – home
FranceBack to France

Clinical trials in St Denis – page 129

3 437 clinical trials in St Denis, France across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

FranceOur site in FranceEssaisCliniques.fr(opens in a new tab)
St Denis at a glance
3 437
clinical trials
  • Research sites2
Type of trial
Recruitment status
Quick filters

3 437 trials in St Denis

Open in trial search

Malformation venous+1

Not yet recruiting

Study of acetylsalicylic acid and diclofenac for treating blood clots in superficial venous malformations in children aged 6 to 17 years

Registered drug
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Centre Hospitalier Regional Universitaire De Tours

Mechanical ventilation+1

Not yet recruiting

Study of dexmedetomidine versus placebo to reduce opioid use in premature babies requiring mechanical ventilation for respiratory distress

Registered drug
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Dexmedetomidine
  • Sponsor:Centre Hospitalier Intercommunal Creteil

Pulmonary fibrosis

Not yet recruiting

A study to evaluate the effectiveness and safety of admilparant in patients with progressive pulmonary fibrosis

Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Admilparant
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Glioblastoma

Not yet recruiting

Phase 3 Randomized Study of Niraparib Tosilate Monohydrate vs. Temozolomide in Newly Diagnosed MGMT Unmethylated Glioblastoma

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Temozolomide
  • Sponsor:Neurotrials LLC

A Study of Ponsegromab Combined with Chemotherapy for Adults with Pancreatic Cancer that has Spread and Caused Weight Loss

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Ponsegromab
  • Sponsor:Pfizer Inc.

A Study of Linvoseltamab Alone and Linvoseltamab with Carfilzomib Compared to Standard Treatment in Adults with Relapsed or Refractory Multiple Myeloma

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Aciclovir
  • Sponsor:Regeneron Pharmaceuticals Inc.

Endocrine ophthalmopathy

Not yet recruiting

A study testing teprotumumab compared to placebo in adult patients with moderate-to-severe active thyroid eye disease

Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Teprotumumab
  • Sponsor:Horizon Therapeutics USA Inc.

Bone sarcoma

Not yet recruiting

Study of regorafenib as maintenance treatment after first-line therapy in patients with bone sarcomas without remaining disease

Investigational
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Regorafenib
  • Sponsor:Centre Leon Berard

Thrombosis prophylaxis

Not yet recruiting

Comparing intermediate and standard doses of enoxaparin to prevent blood clots in patients with severe trauma

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Enoxaparin Sodium
  • Sponsor:Centre Hospitalier Universitaire Grenoble Alpes

Tracheobronchitis bacterial

Not yet recruiting

A study testing inhaled amikacin compared to placebo in critically ill patients with ventilator-associated tracheobronchitis

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Amikacin
  • Sponsor:Centre Hospitalier Regional Universitaire De Tours

Chemical burn

Not yet recruiting

Treatment of Severe Eye Chemical Burns with Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells for Patients with Severe Ocular Chemical Burns

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Dexamethasone
  • Sponsor:Hopital Fondation Adolphe De Rothschild

Uveal melanoma

Not yet recruiting

A study comparing RP2 with nivolumab versus ipilimumab with nivolumab in adults with metastatic uveal melanoma not previously treated with immune checkpoint inhibitors

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Ipilimumab
  • Sponsor:Replimune Inc.

Other cities in France

The busiest research cities in the country

All 376 cities in France

Clinical research in St Denis

What the registry says about research in the country

01 Infectious and Respiratory Diseases

Clinical studies focusing on Chikungunya vaccination effectiveness in vulnerable populations, alongside research into ventilator-associated pneumonia treatment strategies in intensive care settings.

  • Viral infections and prevention
  • Respiratory complications
  • Antimicrobial stewardship

Research includes evaluation of treatments for Herpes Simplex Virus Encephalitis and innovative approaches to respiratory conditions.

02 Oncology Studies

Innovative research into treatment protocols for colorectal cancer and ampullary adenocarcinoma, exploring new therapeutic combinations and surgical approaches.

  • Advanced colorectal treatments
  • Neoadjuvant chemotherapy
  • Surgical outcomes

Studies focus on improving survival rates and treatment efficacy for various cancer types.

03 Autoimmune and Inflammatory Conditions

Research examining treatments for Kawasaki disease, vitiligo, and sarcoidosis, testing innovative therapeutic approaches and combination treatments.

  • Immunological responses
  • Novel treatment combinations
  • Disease management strategies

Investigations into the effectiveness of various immunomodulatory therapies and treatment protocols.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.